ChemicalBook
Chinese English Germany Korean

BEIJING INNO-TECH PHARMIC TECHNOLOGY CO.,LTD 企業の連絡先情報

名前:BEIJING INNO-TECH PHARMIC TECHNOLOGY CO.,LTD
電話番号:15011485209 010-87220093-
ファックス番号:
電子メール:17241816@qq.com
国籍:China
ウェブサイト:www.inno-techpharm.com
商品の合計数:180
1 2

製品カタログ

4-Chloro-N-phenylaniline;Diclofenac sodium impurity 2N-フェニル-4-クロロアニリン1205-71-6C12H10ClN
methyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate;Aclidinium bromide impurity;Aclidinium bromide intermediate2,2-ジ(2-チエニル)グリコール酸メチル26447-85-8C11H10O3S2
2,4-dichloro-N-phenylaniline;Diclofenac sodium impurity2N-(2,4-ジクロロフェニル)ベンゼンアミン58373-59-4C12H9Cl2N
5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde;Vonoprazan impurity;Vonoprazan intermediate5-(2-フルオロフェニル)-1-(ピリジン-3-イルスルホニル)-1H-ピロール-3-カルブアルデヒド881677-11-8C16H11FN2O3S
1-[5-(2-Fluorophenyl)-1H-pyrrol-3-yl]-N-methylmethylamine;Vonoprazan impurity;Vonoprazan intermediate1610043-62-3C12H13FN2
4-(4-nitrophenyl)-1H-pyrazole114474-26-9C9H7N3O2
4-(3-(hydroxymethyl)phenoxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate888967-63-3C14H11NO2
4-((2,2'-bis(hydroxymethyl)-4'-(4-isocyanophenoxy)-[1,1'-biphenyl]-4-yl)oxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate2254541-79-0C28H20N2O4
3-methoxy-3-oxo-2-phenylpropanoic acid; Atropine impurity; Atropine intermediate33315-63-8C10H10O4
Doxofylline Impurity 4;9-((1,3-dioxolan-2-yl)methyl)-1,3-dimethyl-3,9-dihydro-1H-purine-2,6-dione1174289-18-9C11H14N4O4
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile906673-54-9C14H8BrNO2
5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbonitrile;Vonoprazan impurity;Vonoprazan intermediate1807642-39-2C16H10FN3O2S
2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde;Vonoprazan impurity;Vonoprazan intermediate
4-trimethylamino-3-ethoxy-2-butenoic acid;L-carnitine impurity;L-carnitine intermediate857156-75-3C7H15NO3
methyl 5-(2,2-dihydroxyacetyl)-2-hydroxybenzoate; Levothyroxine sodium impurity; Levothyroxine sodium intermediate3-カルボメトキシ-4-ヒドロキシフェニルグリオキサール HYDRATE29754-58-3C10H10O6
5-acetyl-2-hydroxybenzoic acid; Levothyroxine sodium impurity; Levothyroxine sodium intermediate5-アセチル-2-ヒドロキシ安息香酸13110-96-8C9H8O4
2-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate906673-30-1C14H10BNO3
4-hydroxy-2-butenoic acid;L-carnitine impurity;L-carnitine intermediateTRANS-4-ヒドロキシクロトン酸24587-49-3C4H6O3
(S)-2,3,9,10,11-pentamethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinoline;Mivacurium Chloride Impurity 5;Mivacurium Chloride intermediate7668-85-1
(R)-3-hydroxy-1-(3-phenoxypropyl)quinuclidin-1-ium bromide;Aclidinium bromide impurity;Aclidinium bromide intermediate1709021-07-7C16H24NO2+
(E)-Oct-4-ene-1,8-dioic acid(E)-オクト-4-エン-1,8-ニ酸48059-97-8C8H12O4
(Z)-oct-4-enedioic acid; Mivacurium Chloride Impurity 138561-68-1C8H12O4
methyl (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-amino-2-hydroxycyclopentane-1-carboxylate229615-05-8C15H28N2O4
4-(4-bromo-3-(hydroxymethyl)phenoxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate906673-45-8C14H10BrNO2
2-(2-(2-fluorophenyl)-2-oxoethyl)malononitrile;Vonoprazan impurity;Vonoprazan intermediate312307-38-3C11H7FN2O
ethyl (R)-2-acetamido-3-(4-hydroxy-3,5-diiodophenyl)propanoate; Levothyroxine sodium impurity; Levothyroxine sodium intermediate27566-09-2C14H21NO4
7-(β-Hydroxyethyl)theophylline;Doxofylline Impurity 5;7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione7-(2-ヒドロキシエチル)テオフィリン519-37-9C9H12N4O3
4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER4-((TERT-ブチルトキシカルボニル)アミノ)シクロペント-2-エンカルボン酸(1S,4R)-メチル168683-02-1C12H19NO4
(1S,2S,3R,4R)-3-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid2124296-37-1C15H28N4O4
Doxofylline Impurity 3;7-(2,2-diethoxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione43135-57-5C13H20N4O4
8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-oxo-2-phenylpropanoate; Atropine impurity; Atropine intermediateC17H25NO7S
ethyl (S)-2-acetamido-3-(3-chloro-4-hydroxy-5-iodophenyl)propanoate; Levothyroxine sodium impurity; Levothyroxine sodium intermediate889871-06-1C13H15ClINO4
2-chloro-N-phenylaniline;Diclofenac sodium impurity4N-フェニル-2-クロロアニリン1205-40-9C12H10ClN
TAK-4381260141-27-2C21H20FN3O6S
4-(3-formylphenoxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate90178-72-6C14H9NO2
(1R,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid383910-22-3C18H30N2O5
2-hydroxy-2,2-di(thiophen-2-yl)acetic acid;Aclidinium bromide impurity;Aclidinium bromide intermediate4746-63-8C10H8O3S2
Pyridine-3-sulfonic acid;Vonoprazan impurity;Vonoprazan intermediateピリジン-3-スルホン酸636-73-7C5H5NO3S
8-methyl-8-azabicyclo[3.2.1]oct-2-ene; Atropine impurity; Atropine intermediate8-メチル-8-アザビシクロ[3.2.1]オクタ-2-エン529-18-0C8H13N
Crisaboroleクリサボロール906673-24-3C14H10BNO3
4-chloro-3-(pyridin-2-yl)aniline4-クロロ-3-(ピリジン-2-イル)アニリン879088-41-2C11H9ClN2
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl) acetaldehyde;Doxofylline impurity 2;Theophylline-7-acetaldehyde5614-53-9C9H10N4O3
Ibandromate Monosodiumイバンドロネートナトリウム一水和物138926-19-9C9H24NNaO8P2
5-(imidazo[1,2-a]pyridin-6-yl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid;Olprinone Hydrochloride Impurity 1
methyl (R)-5-(2-(tert-butylamino)-1-hydroxyethyl)-2-hydroxybenzoate; Levothyroxine sodium impurity; Levothyroxine sodium intermediate165882-33-7C14H21NO4
5-(4-(aminomethyl)phenoxy)benzo[c][1,2]oxaborol-1(3H)-ol; Crisaborole impurity; Crisaborole intermediate1187230-70-1C14H14BNO3
Acotiamide hydrochloride trihydrateアコチアミド塩酸塩三水和物773092-05-0C21H31ClN4O5S
2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamideビスモデギブ879085-55-9C19H14Cl2N2O3S
2-(isonicotinamido)ethyl nitrate; Nicorandilimpurity; Nicorandil intermediateP-ニコランジル65141-47-1C8H9N3O4
9-Benzyl-3,9-diaza-bicyclo[4.2.1]nonan-4-one(1S,6R)-3,9-ジアザビシクロ[4.2.1]ノナン-4-オン二塩酸塩1210963-09-9C7H12N2O
methyl (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylate229614-51-1C16H30N4O4
1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-5-(2-フルオロフェニル)ピロール-3-カルボキシアルデヒド881674-56-2C11H8FNO
Brexpiprazoleブレクスピプラゾール913611-97-9C25H27N3O2S
(S)-tetrahydrofuran-2-carbothioic S-acid;Faropenem sodium impurity;Faropenem sodium intermediate106560-32-1C10H17N6O13P3
methyl 2-oxo-2-(thiophen-2-yl)acetate;Aclidinium bromide impurity;Aclidinium bromide intermediate2-オキソ-2-(チオフェン-2-イル)酢酸メチル26878-13-7C7H6O3S
(R)-3-(2-chloro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydro-2l5-isoquinolin-2-yl)propan-1-ol;Mivacurium Chloride Impurity791546-70-8
(1S,2S,3S,4R)-3-[(1R)-1-amino-2-ethylbutyl]-4[[(1,1-dimethylethoxy)carbonyl]amino]-2- Methyl hydroxycyclovalerate1988779-13-0C18H34N2O5
5-(2,2-dihydroxyacetyl)-2-hydroxybenzoic acid; Levothyroxine sodium impurity; Levothyroxine sodium intermediate887577-24-4C9H8O6
sodium (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-amino-2-hydroxycyclopentane-1-carboxylate1352062-19-1
ethyl (R)-2-acetamido-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoate; Levothyroxine sodium impurity; Levothyroxine sodium intermediate1795778-96-9C19H17I4NO5
Albuterol sulfate硫酸サルブタモール51022-70-9C13H23NO7S
2-hydroxy-N-phenylacetamide;Diclofenac sodium impurity 1ヒドロキシアセチルアミノベンゼン4746-61-6C8H9NO2
(1S,2S,3S,4R)-Methyl 3-((R)-1-aMino-2-ethylbutyl)-4-(tert-butoxycarbonylaMino)-2-hydroxycyclopentanecarboxylate316173-29-2C18H34N2O5
3-(methyl(pentyl)amino)propanenitrile919491-64-8C9H18N2
1-((1,3-dioxolan-2-yl)methyl)-N-methyl-4-(methylamino)-1H- imidazole-5-carboxamide;Doxofylline impurity 11429636-74-7C10H16N4O3
methyl (3aR,4S,6R,6aS)-6-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-4-carboxylate383910-24-5C18H30N2O5
(R)-3-(2-chloro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydro-2l5-isoquinolin-2-yl)propan-1-ol;Mivacurium Chloride Impurity107740-64-7C25H36NO6.Cl
(S)-3-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-1-(3-phenoxypropyl)quinuclidin-1-ium bromide;Aclidinium bromide impurity;Aclidinium bromide intermediate320346-78-9C26H30BrNO4S2
4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzamide; Crisaborole impurity; Crisaborole intermediate1187188-59-5C14H12BNO4
1-((2-chlorophenyl)diphenylmethyl)-2-methyl-1H-imidazole;Clotrimazole Impurity 1;98751-53-2C23H19ClN2
2,2-dichloro-N-(2,6-dichlorophenyl)-N-phenylacetamide;Diclofenac sodium impurity 6
5-(4-(hydroxymethyl)phenoxy)benzo[c][1,2]oxaborol-1(3H)-ol; Crisaborole impurity; Crisaborole intermediate1187188-60-8C14H13BO4
Ambrisentanアンブリセンタン177036-94-1C22H22N2O4
Mivacurium chlorideミバクリウムクロリド106861-44-3C58H80Cl2N2O14
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile;Vonoprazan impurity;Vonoprazan intermediate1240948-72-4C11H6ClFN2
4-chloro- Benzo[b]thiophene66490-33-3C8H5ClS
2-ChlorodiphenylMethane;Clotrimazole Impurity 4;Clotrimazole impurity L2-クロロジフェニルメタン29921-41-3C13H11Cl
4-(4-(4-bromo-3-formylphenoxy)-3-formylphenoxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate906673-42-5C14H10BNO3
(S)-2-amino-3-(3-chloro-4-hydroxy-5-iodophenyl)propanoic acid; Levothyroxine sodium impurity; Levothyroxine sodium intermediate889871-36-7C9H9ClINO3
2,6-dichloro-4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile; Crisaborole impurity; Crisaborole intermediate2354382-27-5C14H8BCl2NO3
(1R,2R,3S,4S)-3-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acidペラミビル水和物229614-55-5C15H28N4O4
Aclidinium bromideアクリジニウム臭化物320345-99-1C13H10BrN
methyl 3-hydroxy-2-phenylpropanoate; Atropine impurity; Atropine intermediate3967-53-1C10H12O3
(1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester(3AR,4R,6S,6AS)-4-[[(1,1-ジメチルエトキシ)カルボニル]アミノ]-3-(1-エチルプロピル)-3A,5,6,6A-テトラヒドロ-4H-シクロペント[D]イソオキサゾール-6-カルボン酸メチルエステル229613-93-8C18H30N2O5
5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile1240948-77-9C11H7FN2
(R)-quinuclidin-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate;Aclidinium bromide impurity;Aclidinium bromide intermediate320347-97-5C17H19NO3S2
(R)-2-acetamido-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid; Levothyroxine sodium impurity; Levothyroxine sodium intermediate696611-50-4C11H11I2NO4
Clotrimazole Impurity 2;Clotrimazole EP Impurity G;1-((2-chlorophenyl)diphenylmethyl)-4-methyl-1H-imidazole289887-34-9C23H19ClN2
(chloro(4-chlorophenyl)methylene)dibenzene;4-Chlorophenyl-diphenylmethyl Chloride;Clotrimazole Impurity 327023-37-6C19H14Cl2
(S)-quinuclidin-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate;Aclidinium bromide impurity;Aclidinium bromide intermediate2020375-99-7
3,4-Dihydro-6,7-dimethoxy-1-[(3,4,5-trimethoxyphenyl)methyl]isoquinoline61349-11-9C21H25NO5
methyl (1R,4S)-4-((tert-butoxycarbonyl)amino)cyclopent-2-ene-1-carboxylate251326-99-5C12H19NO4
(R)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid; Levothyroxine sodium impurity; Levothyroxine sodium intermediate70438-74-3C17H13I4NO5
N-methylpyridine-3-sulfonamide;Vonoprazan impurity;Vonoprazan intermediate4847-34-1C6H8N2O2S
Ethyl 2-chloro-3-hydroxybutyrate;L-carnitine impurity;L-carnitine intermediate89490-41-5C6H11ClO3
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate383910-25-6C18H30N2O5
2,4,6-trichloro-N-phenylaniline;Diclofenac sodium impurity315362-44-4C12H8Cl3N
1 2
Copyright 2017 © ChemicalBook. All rights reserved